FindTrial
Sign In

Physiotherapy in pregnant women with HIV through call center.

Obstetrics Physiotherapy through digital / teleconsultation: pregnant women living with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-65s7m5
Enrollment
Unknown
Registered
2020-10-06
Start date
2020-11-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

Control group: 60 pregnant women with HIV will receive guidance through booklet and exercise therapy Intervention group: 60 pregnant women with HIV will receive guidance through an exercise therapy b
Other
L01.178.847.652.550
E02.760.169.063.500.387

Sponsors

Dominique Klazcko
Lead Sponsor
Hospital Universitário Gaffrée e Guinle
Collaborator

Eligibility

Sex/Gender
Female
Age
15 Years to 35 Years

Inclusion criteria

Inclusion criteria: Pregnant women; primiparous or secondary; age between 15 and 35 years; body mass index (BMI) between 18 and 35 kg / m2; gestational age at from 16 weeks; single fetus; with no previous complaint of low back pain and urinary incontinence; who is undergoing prenatal care at HUGG; diagnosed with HIV + after the year 2013; to have a cell phone that can receive messages through the WhatsApp Web application as well as videos and that you can have video call communication.

Exclusion criteria

Exclusion criteria: Women with more than two pregnancies; at risk of miscarriage; uterine bleeding; current inflammation and / or urinary infection; cognitive deficit that prevent understanding of the commands; use of illicit drugs; pre-existing pelvic surgery; hypertension; diabetics; showing symptoms of candidiasis; or presenting another STI. Patients diagnosed with COVID-19 will be excluded from the study. Those who during the exercises have symptoms of cough, fever or shortness of breath should immediately stop the study due to symptomatic COVID-19.

Design outcomes

Primary

MeasureTime frame
It is expected to find a decrease or no appearance of pelvic pain, based on the initial assessment questionnaire ;It is expected to find a decrease or no appearance of urinary loss, based on the reduction of positive responses to the Pelvic floor Bother Questionnaire;Improvement in quality of life is expected, based on the increase in the SF-36 score—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactDominique Klaczko

Hospital Universitário Gaffrée e Guinle

dominique.klaczko@gmail.com+55 21 99995-6928

Outcome results

None listed

Source: REBEC (via WHO ICTRP)